MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$49,779K
Net loss
-$49,652K
Unrealized gain (loss) on
marketable securities
-$127K
Interest income
$4,323K
Collaboration Revenue Related
Party
$23,209K
Other Revenue
$8,451K
Loss from operations
-$53,969K
Total revenues
$31,660K
Other income
(expense), net
-$6K
Total operating costs
and expenses
$85,629K
Restructuring
-$230K
Cost of revenues
-$55K
Selling, general and
administrative
$61,997K
Research and development
$23,917K
Back
Back
Income Statement
source: myfinsight.com
Sage Therapeutics, Inc. (SAGE)
Sage Therapeutics, Inc. (SAGE)